Therapeutic efficacy of omalizumab

J Allergy Clin Immunol. 2009 Jan;123(1):114-5. doi: 10.1016/j.jaci.2008.10.053.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Asthmatic Agents / antagonists & inhibitors*
  • Anti-Asthmatic Agents / pharmacokinetics*
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / pharmacokinetics*
  • Antibodies, Monoclonal, Humanized
  • Asthma / blood*
  • Asthma / drug therapy*
  • Asthma / physiopathology
  • Child
  • Double-Blind Method
  • Female
  • Humans
  • Immunoglobulin E / blood*
  • Male
  • Middle Aged
  • Models, Theoretical
  • Omalizumab
  • Peak Expiratory Flow Rate
  • Time Factors

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • Immunoglobulin E